NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

Today, the University of Utah has posted the seminar title of Linda Liau's presentation.

BIOMEDICAL ENGINEERING SEMINAR - LINDA M. LIAU

Friday, April 9, 11:45am – 1pm MDT

BIOENGINEERING ELEVATED SEMINAR SERIES
CELEBRATING 50 YEARS OF BIOMEDICAL ENGINEERING AT THE UNIVERSITY OF UTAH

Overcoming Immunotherapy Resistance in Glioblastoma
Dr. Linda Liau - Professor and W. Eugene Stern chair, Department of Neurosurgery - University of California, Los Angeles

-Outline the historical and current understanding of the mechanisms of
immune responses against glioblastoma
-Elucidate the considerations of timing, sequence, and tumor/patient
heterogeneity in developing combination immunotherapy/vaccine trials
for glioblastoma
-Discuss the common challenges of designing and evaluating clinical
trials of immunotherapy for glioblastoma. How can we overcome these
challenges?

https://www.bme.utah.edu/seminar-series/?trumbaEmbed=view%3Devent%26eventid%3D147261822